CLC Number:
| [1] Hiraishi K, Yoshimoto T, Tsuchiya K, et al. Clinicopathological features of primary aldosteronism associated with subclinical Cushings syndrome[J]. Endocrine J, 2011, 58(7): 543-551. [2] Hogan MJ, Schambelan M, Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism[J]. The Am J Med, 1977, 62(5): 777-782. [3] Katabami T, Matsuba R, Kobayashi H, et al. Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk[J]. Eur J Endocrinol, 2022, 186(6): 645-655. [4] Akehi Y, Yanase T, Motonaga R, et al. High prevalence of diabetes in patients with primary aldosteronism(PA)associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan[J]. Diabetes Care, 2019, 42(5): 938-945. [5] Arlt W, Lang K, Sitch AJ, et al. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism[J]. JCI Insight, 2017, 2(8): 93136. [6] Teragawa H, Oshita C, Orita Y, et al. Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushings syndrome: a case report[J]. World J Clin Cases, 2021, 9(5): 1119-1126. [7] Hu L, Ji W, Guo M, et al. Case report: primary aldosteronism and subclinical cushing syndrome in a 49-year-old woman with hypertension plus hypokalaemia[J]. Front Cardiovasc Med, 2022, 9: 911333. doi:10.3389/fcvm.2022.1055119. [8] Yoon V, Heyliger A, Maekawa T, et al. Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids[J].Endocrinol Diabetes Metab Case Rep, 2013, 2013: 130042. doi:10.1530/edm-13-0042. [9] Vicennati V, Repaci A, di Dalmazi G, et al. Combined aldosterone and cortisol secretion by adrenal incidentaloma[J]. Int J Surg Pathol, 2012, 20(3): 316-319. [10] 中华医学会内分泌学分会.原发性醛固酮增多症诊断治疗的专家共识(2020版)[J].中华内分泌代谢杂志, 2020, 36(9): 727-736. Chinese Society of Endocrinology, Chinese Medical Association. Expert consensus on the diagnosis and treatment of primary aldosteronism(2020)[J]. Chinese Journal of Endocrinology and Metabolism, 2020, 36(9): 727-736. [11] 李乐乐,窦京涛. 如何从肾上腺意外瘤中甄选出亚临床库欣综合征[J]. 中国实用内科杂志,2017, 37(10): 867-870. LI Lele, DOU Jingtao. Proposed diagnostic strategy for subclinical Cushings syndrome in patients with adrenal incidentaloma[J]. China Industrial Economics, 2017, 37(10): 867-870. [12] Akehi Y, Kawate H, Murase K, et al. Proposed diagnostic criteria for subclinical Cushings syndrome associated with adrenal incidentaloma[J]. Endocr J, 2013, 60(7): 903-912. [13] Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia Type 1 and 2[J]. Presse Med, 2018, 47(9): 722-731. [14] Thakker RV, Newey PJ, Walls GV,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1(MEN1)[J]. J Clin Endocrinol Metab, 2012, 97(9): 2990-3011. [15] Funder JW, Carey RM, Fardella C, et al.Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2008, 93(9): 3266-3281. [16] Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[J]. Hypertension, 2014, 63(1): 151-160. [17] Goupil R, Wolley M, Ungerer J, et al. Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion[J]. Endocrinol Diabetes Metab Case Rep, 2015, 2015: 150075.doi: 10.1530/EDM-15-0075. [18] Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors[J]. Endocr Pathol, 2022, 33(1): 155-196. [19] Scortegagna M, Berthon A, Settas N, et al. The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion[J]. JCI Insight, 2017, 2(23): 97128. [20] Nanba K, Tsuiki M, Sawai K, et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry[J]. J Clin Endocrinol Metab, 2013, 98(4): 1567-1574. [21] Nakamura Y, Yamazaki Y, Tezuka Y, et al. Expression of CYP11B2 in aldosterone-producing adrenocortical adenoma: regulatory mechanisms and clinical significance[J]. Tohoku J Exp Med, 2016, 240(3): 183-190. [22] Ahn CH, Na HY, Park SY, et al. Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism[J]. Clin Endocrinol, 2022, 96(1): 30-39. [23] Raff H, Carroll T. Cushings syndrome: from physiological principles to diagnosis and clinical care[J]. J Physiol, 2015, 593(3): 493-506. [24] Ferriere A, Tabarin A. Cushings syndrome: treatment and new therapeutic approaches[J]. Best Pract Res Clin Endocrinol Metab, 2020, 34(2): 101381. |
| [1] | YU Shujuan, WANG Meijuan, CHEN Li, CAO Yingjuan LYU Xiaoyan, LIU Xueyan, LIN Peng, YAN Jingzheng. Influencing factors of mild cognitive impairment in elderly patients with type 2 diabetes [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 108-112. |
| [2] | LYU Li, JIANG Lu, CHEN Shihong, ZHUANG Xianghua, SONG Yuwen, WANG Dianhui, AN Wenjuan, LI Qian, PAN Zhe. Related factors of osteoporosis in 210 postmenopausal women with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 19-25. |
| [3] | LI Han, FU Tingting, ZHANG Lei, YAN Bing, SUN Tao, GUO Feng, YIN Xiao. Effects of PPARγ agonist rosiglitazone on the differentiation of beige adipocytes in 24 obese individuals [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 8-13. |
| [4] | HU Yanwen, WANG Zhiyuan, YU Wanjiang, ZHAO Huichen, HAN Heli, XU Zhipeng, MA Hong, ZHANG Yuchao, LIU Yuantao. Correlation of fat distribution with metabolic syndrome and glucose metabolism in 52 obese patients [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 101-106. |
| [5] | DING Hualin, LI Yangyang, YU Fengyuan, ZHAN Weiwei, YU Suguo. Daglixamine inhibits renal fibrosis in rats with diabetic nephropathy via Klotho/TGF-β1 signaling pathway [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 75-80. |
| [6] | TANG Bo, SHAO Jing, CUI Jing, SUN Jianping. A mechanism study on the association of type 2 diabetes and high-density lipoprotein [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 99-106. |
| [7] | WANG Min, WANG Chunhua, LIU Hongli, HE Zhiliang, CUI Weiwei, WANG Lei, LIU Jiejun. Impacts of leptin resistance developed in boyhood on the health condition of young adults [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 114-118. |
| [8] | LI Hongzhi, SHEN Yongchao, LIU Jieting, ZHAO Xiaojin, CHU Yanhui, YUAN Xiaohuan. An 11β-HSD1 inhibitor improves insulin sensitivity in db/db mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 59-64. |
| [9] | GONG Luwei, ZHOU Lizhen, SU Guohai. Perindopril ameliorates cardiac dysfunction via Akt-FoxO1 pathway in diabetic cardiomyopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 65-70. |
| [10] | LIU He, LIU Fuqiang, HOU Xinguo, CHEN Li. A study of 11β-hydroxylase defect induced by a novel CYP11B1 gene mutation in one family [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 85-89. |
| [11] | LIU Pan, HE Tianyi, ZHAO Ruxing, SUN Yu, CHEN Li. Regulating effect of Bailing capsule on autoimmunity in patients with Graves disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 90-95. |
| [12] | JI Yuanyuan, BAO Jingbo, ZHAO Xu, CAO Luning, CUI Min, ZHANG Na, YU Lingzhi. IL-17F promotes the proliferation, mineralization and expressions of Runx2 and Osterix in rat osteoblasts [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 24-29. |
| [13] | ZHANG Liang, XU Min, ZHUANG Xianghua, LOU Fuchen, LOU Nengjun, LÜ Li, GUO Wenjuan, ZHENG Fengjie, CHEN Shihong. An investigation of endoplasmic reticulum stress and apoptosis in diabetic peripheral neuropathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 13-17. |
| [14] | CAO Jin, JI Xiaokang, SUN Xiubin, JIANG Zheng, XUE Fuzhong. The relationship between γ-glutamyltransferase and hyperuricemia: a cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 124-128. |
| [15] | ZHANG Guang, WANG Guangyin, WU Hongyan, ZHANG Hongyu, WANG Tingting, LI Jiqing, LI Min, KANG Fengling, LIU Yanxun, XUE Fuzhong. A prediction model of hyperlipidemia risk based on the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 72-76. |
|
||
